Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mpdhp.2020.11.009 http://scihub22266oqcxt.onion/10.1016/j.mpdhp.2020.11.009 33312229!7717771!33312229     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diagn+Histopathol+(Oxf) 2021 ; 27 (3): 123-127 Nephropedia Template TP {{tp|p=33312229|t=2021. Histopathology features of the lung in COVID-19 patients |pdf=|usr=}}{{33312229}} gab.com Text Histopathology features of the lung in COVID-19 patients JO: Diagn Histopathol (Oxf) http://www.kidney.de/pget.php?&tw=1&pmid=33312229 #FOAvip COVID-19 is the infectious disease caused by the recently discovered coronavirus, SARS-CoV-2, unknown before the outbreak in Wuhan, China, in December 2019. COVID-19 is a pandemic, infectious disease that has simultaneously affected many countries globally. The leading cause of dead in patients with COVID-19 is hypoxic respiratory failure from acute respiratory distress syndrome (ARDS). Diffuse alveolar damage (DAD) is the histopathological pattern commonly described in all the postmortem series up to date. DAD is divided into two phases, and depending on the length of the disease, the morphological features seen in the specimens vary. There is an acute/exudative phase, which occurs during the first week after the pulmonary injury, following by the organizing/proliferative phase. Additional features detailed include vascular thrombosis, endothelialitis and angiogenesis. Interestingly, there is an ongoing discussion about the specificity of these changes, as diffuse alveolar damage seen in other viral infections show similar features. Twit Text FOAVip Histopathology features of the lung in COVID-19 patients ????Diagn Histopathol (Oxf) http://www.kidney.de/pget.php?&tw=1&pmid=33312229 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33312229 #FOAvip English Wikipedia <ref>{{Cite pmid|33312229}}</ref> Histopathology features of the lung in COVID-19 patients #MMPMID33312229 Angeles Montero-Fernandez M; Pardo-Garcia R Diagn Histopathol (Oxf) 2021[Mar]; 27 (3): 123-127 PMID33312229show ga COVID-19 is the infectious disease caused by the recently discovered coronavirus, SARS-CoV-2, unknown before the outbreak in Wuhan, China, in December 2019. COVID-19 is a pandemic, infectious disease that has simultaneously affected many countries globally. The leading cause of dead in patients with COVID-19 is hypoxic respiratory failure from acute respiratory distress syndrome (ARDS). Diffuse alveolar damage (DAD) is the histopathological pattern commonly described in all the postmortem series up to date. DAD is divided into two phases, and depending on the length of the disease, the morphological features seen in the specimens vary. There is an acute/exudative phase, which occurs during the first week after the pulmonary injury, following by the organizing/proliferative phase. Additional features detailed include vascular thrombosis, endothelialitis and angiogenesis. Interestingly, there is an ongoing discussion about the specificity of these changes, as diffuse alveolar damage seen in other viral infections show similar features. äHistopathology features of the lung in COVID-19 patients (epmc).pdf DeepDyve Pubget Overpricing